University of Regensburg Publication Server (University of Regensburg) · 2005 · 341 citations · 0 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyBrain TumorsGlioblastomaGlioma RadiotherapyMalignant NeoplasmsTargeted Cancer TherapyTumor Suppressor GenesGlioblastoma ChemotherapyGlioblastoma Drug TherapyGlioblastoma Therapeutic ResistanceGlioma ChemotherapyTemozolomide Therapy
Patients with glioblastoma containing a methylated MGMT promoter benefited from temozolomide, whereas those who did not have a methylated MGMT promoter did not have such a benefit.